Stock Events

Stock Events

CervoMed 

$2.65
78
+$0.02+0.76% 20:00 Today
-$0.03-1.13%20:10After hours

Statistics

Day High
2.73
Day Low
2.6
52W High
10.89
52W Low
2.13
Volume
219,958
Avg. Volume
5,626,812
Mkt Cap
40.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.86
-0.74
-0.61
-0.49
Expected EPS
-0.49
Actual EPS
N/A

Financials

-672.97%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.01MRevenue
-26.97MNet Income

Analyst Ratings

21.20Average Price Target
The highest estimate is 31.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CRVO. It's not an investment recommendation.
Intel
11
INTC
Apple
10
AAPL
NVIDIA
10
NVDA
Broadcom
10
AVGO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap119.49B
Medtronic is a major player in the medical devices sector, directly competing with CervoMed in multiple healthcare technology markets.
Boston Scientific
BSX
Mkt Cap73B
Boston Scientific competes with CervoMed in developing advanced medical devices for various therapeutic areas.
Stryker
SYK
Mkt Cap126.37B
Stryker operates in the same sectors as CervoMed, particularly in orthopedics and neurotechnology, making them direct competitors.
Abbott Laboratories
ABT
Mkt Cap201.83B
Abbott Laboratories offers a broad range of medical devices and diagnostics, overlapping with CervoMed's product lines.
Intuitive Surgical
ISRG
Mkt Cap133.83B
Intuitive Surgical provides robotic-assisted surgical systems, competing with CervoMed's innovations in medical technology.
Zimmer Biomet
ZBH
Mkt Cap19.26B
Zimmer Biomet competes in the musculoskeletal healthcare sector, directly challenging CervoMed's offerings in orthopedic devices.
Edwards Lifesciences
EW
Mkt Cap51.75B
Edwards Lifesciences specializes in heart valve therapy and critical care, areas where CervoMed also operates.
Baxter International
BAX
Mkt Cap13.62B
Baxter International competes with CervoMed in the development and manufacturing of medical products, including hospital and renal care devices.
Resmed
RMD
Mkt Cap33.4B
ResMed is known for its sleep and respiratory care devices, competing with CervoMed's products in similar therapeutic areas.

About

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Show more...
CEO
John J. Alam
Employees
15
Country
United States
ISIN
US15713L1098
WKN
000A3ES01

Listings

STU
DE
DP8.STU
F
DE
DP8.F
XNAS
US
CRVO
BOATS
BOATS
CRVO.BOATS

0 Comments

Share your thoughts

FAQ

What is CervoMed stock price today?▼
The current price of CRVO is $2.65 USD — it has increased by +0.76% in the past 24 hours. Watch CervoMed stock price performance more closely on the chart.
What is CervoMed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange CervoMed stocks are traded under the ticker CRVO.
Is CervoMed stock price growing?▼
CRVO stock has risen by +1.53% compared to the previous week, the month change is a -0.38% fall, over the last year CervoMed has showed a -71.9% decrease.
What is CervoMed market cap?▼
Today CervoMed has the market capitalization of 40.07M
When is the next CervoMed earnings date?▼
CervoMed is going to release the next earnings report on November 16, 2026.
What were CervoMed earnings last quarter?▼
CRVO earnings for the last quarter are -0.64 USD per share, whereas the estimation was -0.8 USD resulting in a +19.69% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is CervoMed revenue for the last year?▼
CervoMed revenue for the last year amounts to 4.01M USD.
What is CervoMed net income for the last year?▼
CRVO net income for the last year is -26.97M USD.
How many employees does CervoMed have?▼
As of August 25, 2026, the company has 15 employees.
In which sector is CervoMed located?▼
CervoMed operates in the Health & Wellness sector.
When did CervoMed complete a stock split?▼
The last stock split for CervoMed was on August 17, 2023 with a ratio of 1:1.5.
Where is CervoMed headquartered?▼
CervoMed is headquartered in BOSTON, United States.